Pyrazolones as a potential anticancer scaffold: Recent trends and future perspectives

HTML Full Text

Reference

Ahsan MJ, Samy JG, Jain CB, Dutt KR, Khalilullah H, Nomani MS. Discovery of novel anti-tubercular 1,5-dimethyl-2-phenyl-4-([5- (arylamino)-1,3,4-oxadiazol-2-yl]methylamino)-1,2-dihydro-3H-pyrazol3-one analogues. Bioorg Med Chem Lett, 2012; 22:969-72. https://doi.org/10.1016/j.bmcl.2011.12.014
Akcha S, Gómez-Ruiz S, Kellou-Tairi S, Lezama L, Pérez FB, Benali-Baitich O. Synthesis, characterization, solution equilibria, DFT study, DNA binding affinity and cytotoxic properties of a cobalt(II) complex with a 5-pyrazolone ligand. Inorg Chim Acta, 2018; 482: 738-48. https://doi.org/10.1016/j.ica.2018.06.051
Akondi AM, Kantam ML, Trivedi R, Bharatam J, Vemulapalli SPB, Bhargava SK, Prakasham RS. Ce/SiO2 composite as an efficient catalyst for the multicomponent one-pot synthesis of substituted pyrazolones in aqueous media and their antimicrobial activities. J Mol Catal A Chem, 2016; 411:325-36. https://doi.org/10.1016/j.molcata.2015.11.004
Bae M, Oh J, Bae ES, Oh J, Hur J, Suh YG, Lee SK, Shin J, Oh DC. WS9326H, an antiangiogenic pyrazolone-bearing peptide from an intertidal mudflat actinomycete. Org Lett, 2018; 20:1999-02. https://doi.org/10.1021/acs.orglett.8b00546
Bakr EA, Al-Hefnawy GB, Awad MK, Abd-Elatty HH, Youssef MS. New Ni(II), Pd(II) and Pt(II) complexes coordinated to azo pyrazolone ligand with a potent anti-tumor activity: synthesis, characterization, DFT and DNA cleavage studies. Appl Organomet Chem, 2017; 32:4104-7. Brogden RN. Pyrazolone derivatives. Drugs, 1986; 32:60-70. https://doi.org/10.1002/aoc.4104
Brune K. The early history of non-opioid analgesics. Acute Pain, 1997; 1:33-40. https://doi.org/10.1016/S1366-0071(97)80033-2
Burja B, ÄŒimbora-Zovko T, Tomić S, Jelušić T, Kočevar M, Polanc S, Osmak M. Pyrazolone-fused combretastatins and their precursors: synthesis, cytotoxicity, antitubulin activity and molecular modeling studies. Bioorg Med Chem, 2010; 18:2375-87. https://doi.org/10.1016/j.bmc.2010.03.006
Caruso F, Monti E, Matthews J, Rossi M, Gariboldi MB, Pettinari C, Pettinari R, Marchetti F. Synthesis, characterization, and antitumor activity of water-soluble (Arene)ruthenium(II) derivatives of 1,3-Dimethyl-4-acylpyrazolon-5-ato ligands. first example of Ru(arene) (ligand) antitumor species involving simultaneous Ru-N7(guanine) bonding and ligand intercalation to DNA. Inorg Chem, 2014; 53:3668-77. https://doi.org/10.1021/ic403170y
Casas JS, Castellano EE, Ellena J, García-Tasende MS, PérezParallé ML, Sánchez A, Sánchez-González Á, Sordo J, Touceda Á. New Pd(II) and Pt(II) complexes with N, S-chelated pyrazolonate ligands: molecular and supramolecular structure and preliminary study of their in vitro antitumoral activity. J Inorg Biochem, 2008; 102:33-45. https://doi.org/10.1016/j.jinorgbio.2007.06.032
Counihan JL, Grossman EA, Nomura DK. Cancer metabolism: current understanding and therapies. Chem Rev, 2018; 118:6893-23. https://doi.org/10.1021/acs.chemrev.7b00775
Cutsem, EV, Karaszewska, B, Kang, YK, Chung, HV, Shankaran, V, Siena, S, Go, NF, Yang, H, Schupp, M, Cunningham, D. A multicenter phase II study of AMG 337 in patients with MET-amplified gastric/gastroesophageal junction/esophageal adenocarcinoma and other MET-amplified solid tumors. Clin Cancer Res, 2019; 25:1445-56. https://doi.org/10.1158/1078-0432.CCR-18-1337
De Pascali SA, Migoni D, Monari M, Pettinari C, Marchetti F, Muscella A, Fanizzi FP. Synthesis, crystal structure, and biological study of PtII complexes with 4-Acyl-5-pyrazolones. Eur J Inorg Chem, 2014; 7:1249-59. https://doi.org/10.1002/ejic.201301479
Deshmukh P, Soni PK, Kankoriya A, Halve AK, Dixit R. 4-Aminoantipyrine: a significant tool for the synthesis of biologically active schiff bases and metal complexes. Int J Pharma Sci Rev Res, 2015; 34:162-70.
Gaber M, Khedr AM, Mansour MA, Elsharkawy M. Nanosynthesis, characterization, modeling and molecular docking analysis of Mn (II), Co (II), Cr (III) and Cu (II) complexes with azo pyrazolone ligand as new favourable antimicrobial and antitumor agents. Appl Organomet Chem, 2018; 1:4606-8. https://doi.org/10.1002/aoc.4606
Gao F, Zhang X, Wang TF, Xiao JQ. Quinolone hybrids and their anti-cancer activities: an overview. Eur J Med Chem, 2019; 165:59-79. https://doi.org/10.1016/j.ejmech.2019.01.017
Ghorab MM, El-Gazzar MG, Alsaid MS. Synthesis, characterization and anti-breast cancer activity of new 4-aminoantipyrinebased heterocycles. Int J Mol Sci, 2014; 15:7539-53. https://doi.org/10.3390/ijms15057539
Gouda MA, Eldien HF, Girges MM, Berghot MA. Synthesis and antitumor evaluation of thiophene based azo dyes incorporating pyrazolone moiety. J Saudi Chem Soc, 2016; 20:151-57. https://doi.org/10.1016/j.jscs.2012.06.004
Gouhar, RS, Fathalla OA, Abd El-Karim SS. Synthesis and anticancer screening of some novel substituted pyrazole derivatives. Der Pharma Chem, 2013; 5:225-33
Gu W, Dai Y, Qiang H, Shi W, Liao C, Zhao F, Huang W. Discovery of novel 2-substituted-4-(2-fluorophenoxy) pyridine derivatives possessing pyrazolone and triazole moieties as dual c-Met/VEGFR-2 receptor tyrosine kinase inhibitors. Bioorg Chem, 2017; 72:116-22. https://doi.org/10.1016/j.bioorg.2017.04.001
Islam MS, Wang CY, Zheng JY, Paudyal N, Zhu YL, Sun HX. The potential role of tubeimosides in cancer prevention and treatment. Eur J Med Chem, 2019; 162:109-21. https://doi.org/10.1016/j.ejmech.2018.11.001
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Tumor J Clin, 2011; 61:69-90. https://doi.org/10.3322/caac.20107
Kandhasamy S, Ramanathan G, Muthukumar T, Thyagarajan S, Umamaheshwari N, Santhanakrishnan VP, Sivagnanam UT, Perumal PT. Nanofibrous matrixes with biologically active hydroxybenzophenazine pyrazolone compound for cancer theranostics. Mat Sci Eng, 2017; 74:70-5. https://doi.org/10.1016/j.msec.2017.01.001
Katritzky AR, Rees CW, Scriven EF. Comprehensive heterocyclic chemistry II. 5th edition, Pergamon, Oxford, UK, pp 301-9, 1996.
Kavitha Rani PR, Sheena Mary Y, Fernandez A, Anu Priya S, Shyma Mary Y, Thomas R. Single-crystal XRD, DFT investigations and molecular docking study of 2-((1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro1H-pyrazol-4-yl)amino)naphthalene-1,4-dione as a potential anti-cancer lead molecule. Comput Biol Chem, 2018, 78:153-64. https://doi.org/10.1016/j.compbiolchem.2018.11.022
Kulkarni RC, Madar JM, Shastri SL, Shaikh F, Naik NS, Chougale RB, Shastri LA, Joshi SD, Dixit SR, Sunagar VA. Green synthesis of coumarin-pyrazolone hybrids: in vitro anticancer and anti-inflammatory activities and their computational study on COX-2 enzyme. Chem Data Collect, 2018; 17:497-06. https://doi.org/10.1016/j.cdc.2018.11.004
Li Y, Zhao J, He CC, Zhang L, Sun SR, Xu GC. Synthesis, crystal structure and biological activity of two Mn complexes with 4-acyl pyrazolone derivatives. J Inorg Biochem, 2015; 150:28-7. https://doi.org/10.1016/j.jinorgbio.2015.06.003
Lunagariya MV, Thakor KP, Kanthecha DN, Patel MN. Synthesis, characterization and biological applications of substituted pyrazolone corebased platinum(II) organometallic compounds. J Organomet Chem, 2018; 854:49-3. https://doi.org/10.1016/j.jorganchem.2017.11.012
Mahajan SS, Scian M, Sripathy S, Posakony J, Lao U, Loe TK, Leko V, Thalhofer A, Schuler AD, Bedalov A, Simon JA. Development of pyrazolone and isoxazol-5-one cambinol analogues as sirtuin inhibitors. J Med Chem, 2014; 57:3283-94. https://doi.org/10.1021/jm4018064
Mariappan G, Saha BP, Sutharson L, Singh A, Garg S, Pandey L, Kumar D. Analgesic, anti-inflammatory, antipyretic and toxicological evaluation of some newer 3-methyl pyrazolone derivatives. Saudi Pharm J, 2011; 19:115-22. https://doi.org/10.1016/j.jsps.2011.01.003
Marković V, Erić S, Stanojković T, Gligorijević N, Aranđelović S, Todorović N, Trifunović S, Manojlović N, Jelić R, Joksović MD. Antiproliferative activity and QSAR studies of a series of new 4-aminomethylidene derivatives of some pyrazol-5-ones. Bioorg Med Chem Lett, 2011; 21:4416-21. https://doi.org/10.1016/j.bmcl.2011.06.025
Metwally, NH, Mohamed, MS, Ragb, EA. Design, synthesis, anticancer evaluation, molecular docking and cell cycle analysis of 3-methyl-4,7-dihydropyrazolo[1,5-a]pyrimidine derivatives as potent histone lysine demethylases (KDM) inhibitors and apoptosis inducers. Bioorg Chem, 2019; 88:1029-32. https://doi.org/10.1016/j.bioorg.2019.102929
Modi JS, Kulkarni MV. Vascular endothelial growth factor receptor (VEGFR-2)/KDR inhibitors: medicinal chemistry perspective. Med Drug Discov, 2019; 2:100009-11. https://doi.org/10.1016/j.medidd.2019.100009
Montana M, Mathias F, Terme T, Vanelle P. Antitumoral activity of quinoxaline derivatives: a systematic review. Eur J Med Chem, 2019; 163:136-47. https://doi.org/10.1016/j.ejmech.2018.11.059
Mosoarca EM, Pantenburg I, Tudose R, Meyer G, Popa NC, Han A, Alexandrova R, Kalfin R, Linert W, Costisor O. Synthesis, structure and cytotoxic activity of mixed-valent Cu(I)/Cu(II) salt containing a pyrazolone derivative as a ligand. Inorg Chim Acta, 2011; 370:460-68. https://doi.org/10.1016/j.ica.2011.02.035
Mu LM, Ju RJ, Liu R, Bu YZ, Zhang JY, Li XQ, Zeng F, Lu WL. Dual-functional drug liposomes in the treatment of resistant cancers. Adv Drug Deliv Rev, 2017; 115:46-6. https://doi.org/10.1016/j.addr.2017.04.006
Narayana Rao DV, Raghavendra Guru Prasad A, Spoorthy YN, Raghunatha Rao D, Ravindranath L K. In vitro microbiological evaluation of novel bis pyrazolones. Ann Pharmacol Franç, 2014; 72:101-6. https://doi.org/10.1016/j.pharma.2013.11.005
Parmar N, Teraiya S, Patel R, Barad H, Jajda H, Thakkar V. Synthesis, antimicrobial and antioxidant activities of some 5-pyrazolone based Schiff bases. J Saudi Chem Soc, 2015; 19:36-1. https://doi.org/10.1016/j.jscs.2011.12.014
Paulpandiyan R, Raman N. DNA binding propensity and nuclease efficacy of bio sensitive Schiff base complexes containing pyrazolone moiety: synthesis and characterization. J Mol Struct, 2016; 1125:374-82. https://doi.org/10.1016/j.molstruc.2016.07.003
Pettinari R, Marchetti F, Di Nicola C, Pettinari C, Galindo A, Petrelli R, Cappellacci L, Cuccioloni M, Bonfili L, Eleuteri AM, Guedes da Silva MFC, Pombeiro AJL. Ligand design for N,O- or N, N-pyrazolonebased hydrazones ruthenium(II)-arene complexes and investigation of their anticancer activity. Inorg Chem, 2018; 57:14123-3. https://doi.org/10.1021/acs.inorgchem.8b01935
Pettinari R, Marchetti F, Pettinari C, Petrini A, Scopelliti R, Clavel CM, Dyson PJ. Synthesis, structure, and antiproliferative activity of ruthenium(II) arene complexes with N,O-chelating pyrazolone-based β-Ketoamine ligands. Inorg Chem, 2014; 53:13105-11. https://doi.org/10.1021/ic502274b
Rashid H, Xu Y, Muhammad Y, Wang L, Jiang J. Research advances on anticancer activities of matrine and its derivatives: an updated overview. Eur J Med Chem, 2019; 161:205-38. https://doi.org/10.1016/j.ejmech.2018.10.037
Rizk HF, Ibrahim SA, El-Borai MA. Synthesis, dyeing performance on polyester fiber and antimicrobial studies of some novel pyrazolotriazine and pyrazolyl pyrazolone azo dyes. Arab J Chem, 2017; 10:3303-9. https://doi.org/10.1016/j.arabjc.2014.01.008
Saad FA, El-Metwaly NM, Farghaly TA, El-Ghalban MG, AlHazmi GA, Saleh KA, Alfaifi MY. Illustration for series of new metal ion complexes extracted from pyrazolone derivative, spectral, thermal, QSAR, DFT/B3LYP, docking, and antitumor investigations. J Mol Liq, 2016; 229:614-27. https://doi.org/10.1016/j.molliq.2016.11.035
Saidachary G, Veera Prasad K, Divya D, Singh A, Ramesh U, Sridhar B, China Raju B. Convenient one-pot synthesis, anti-mycobacterial and anticancer activities of novel benzoxepinoisoxazolones and pyrazolones. Eur J Med Chem, 2014; 76:460-69. https://doi.org/10.1016/j.ejmech.2014.02.042
Singh N, Krishnakumar S, Kanwar RK, Cheung CHA, Kanwar JR. Clinical aspects for surviving: a crucial molecule for targeting drugresistant cancers. Drug Discov Today, 2015; 20:578-87. https://doi.org/10.1016/j.drudis.2014.11.013
Sivakumar KK, Rajasekaran A, Senthilkumar P, Wattamwar PP. Conventional and microwave-assisted synthesis of pyrazolone Mannich bases possessing anti-inflammatory, analgesic, ulcerogenic effect and antimicrobial properties. Bioorg Med Chem Lett, 2014; 24:2940-44. https://doi.org/10.1016/j.bmcl.2014.04.067
Stornaiuolo M, La Regina G, Passacantilli S, Grassia G, Coluccia A, La Pietra V, Giustiniano M, Cassese H, Di Maro S, Brancaccio D, Taliani S. Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents. J Med Chem, 2015; 58:2135-48. https://doi.org/10.1021/jm501123r
Tang, Y, Rong, X, Hu, W, Li, G, Yang, X, Yang, J, Xu, P, Luo, J. Effect of edaravone on radiation-induced brain necrosis in patients with nasopharyngeal carcinoma after radiotherapy: a randomized controlled trial. J Neurooncol, 2014, 120:441-47. https://doi.org/10.1007/s11060-014-1573-4
Tok F, KoçyiÄŸit-KaymakçıoÄŸlu B, Nurpelin SaÄŸlık B, Levent S, Özkay Y, Asım Kaplancıklı Z. Synthesis and biological evaluation of new pyrazolone schiff bases as monoamine oxidase and cholinesterase inhibitors. Bioorg Chem, 2019; 84:41-50. https://doi.org/10.1016/j.bioorg.2018.11.016
Tripathy R, Ghose A, Singh J, Bacon ER, Angeles TS, Yang SX, Albom MS, Aimone LD, Herman JL, Mallamo JP. 1,2,3-Thiadiazole substituted pyrazolones as potent KDR/VEGFR-2 kinase inhibitors. Bioorg Med Chem Lett, 2007; 17:1793-98. https://doi.org/10.1016/j.bmcl.2006.12.054
Tripathy R, McHugh RJ, Ghose AK, Ott GR, Angeles TS, Albom MS, Huang Z, Aimone LD, Cheng M, Dorsey BD. Pyrazolonebased anaplastic lymphoma kinase (ALK) inhibitors: control of selectivity by a benzyloxy group. Bioorg Med Chem Lett, 2011; 21:7261-64. https://doi.org/10.1016/j.bmcl.2011.10.055
Tüzün, B. Investi̇gati̇on of pyrazoly derivatives schi̇ff base li̇gands and thei̇r metal complexes used as anti-cancer drug. Spectrochim Acta A Mol Biomol Spectrosc, 2019, 15; 11763-67 https://doi.org/10.1016/j.saa.2019.117663
Vyas KM, Jadeja RN, Patel D, Devkar RV, Gupta VK. A new pyrazolone based ternary Cu (II) complex: Synthesis, characterization, crystal structure, DNA binding, protein binding and anti-cancer activity towards A549 human lung carcinoma cells with a minimum cytotoxicity to non-cancerous cells. Polyhedron, 2013, 28; 65:262-74. https://doi.org/10.1016/j.poly.2013.08.051
Vyas KM, Jadeja RN, Patel D, Devkar RV, Gupta VK. Effect of ligand substitution in pyrazolone based binary and ternary Cu(II) complexes on DNA binding, protein binding and anti-cancer activity on A549 lung carcinoma cell lines. Polyhedron, 2014; 80:20-33. https://doi.org/10.1016/j.poly.2013.12.037
Weast RC. Hand book of chemistry and physics. CRC Press Inc, Cleveland, Ohio, p 58, 1977.
Wiley R, Wiley P. Pyrazolones, pyrazolidones and derivatives: the chemistry of heterocyclic compounds. 20th edition, A Weissberger. Interscience Publishers, New York, NY, pp 1-12, 1964. https://doi.org/10.1002/9780470186817
Yousuf S, Khan KM, Salar U, Chigurupati, S, Muhammad MT, Wadood A, Aldubayan M, Vijayan V, Riaz M, Perveen S. 2ʹ-Aryl and 4ʹ-arylidene substituted pyrazolones: as potential α-amylase inhibitors. Eur J Med Chem, 2018; 159:47-58. https://doi.org/10.1016/j.ejmech.2018.09.052
Zhang Y, Zhang L, Liu L, Guo J, Wu D, Xu G, Wang X, Jia D. Anticancer activity, structure, and theoretical calculation of N-(1-phenyl3-methyl-4-propyl-pyrazolone-5)-salicylidene hydrazone and it's copper(II) complex. Inorganica Chim Acta, 2010; 363:289-93. https://doi.org/10.1016/j.ica.2009.08.017
Zhao J, Zhang L, Li J, Wu T, Wang M, Xu G, Zhang F, Liu L, Yang J, Sun S. A novel pyrazolone-based derivative induces apoptosis in human esophageal cells via reactive oxygen species (ROS) generation and caspase-dependent mitochondria-mediated pathway. Chem Biol Interact, 2015; 231:1-9.https://doi.org/10.1016/j.cbi.2015.02.004
Zhuang C, Guan X, Ma H, Cong H, Zhang W, Miao Z. Small molecule-drug conjugates: a novel strategy for cancer-targeted treatment. Eur J Med Chem, 2019; 163:883-95. https://doi.org/10.1016/j.ejmech.2018.12.035
Zong Z, Wei X, Yan X, Fan Y.Crystal structures and anticancer activities of five novel pyrazolone-enamine transition metal complexes with 4-benzoyl-3-methyl-1-phenyl-2-pyrazolin-5-one. J Mol Struct, 2018; 1171:333-39. https://doi.org/10.1016/j.molstruc.2018.06.019

Article Metrics

Similar Articles

Related Search

By author names

Adhikari S [PubMed] [Google Scholar ]
Singh M [PubMed] [Google Scholar ]
Sharma P [PubMed] [Google Scholar ]
Arora S [PubMed] [Google Scholar ]